In contrast, the decrease in activity of ELOVL2, an enzyme involved in fatty acid metabolism, only in the Testos but not E2 rats suggests the potential for a functional role for this enzyme in the development of NAFLD. This evidence concerns the gene ELOVL2 and metabolic dysfunction-associated steatotic liver disease.